STAT6 and neoplasm: For instance, loading exosomes with antisense oligonucleotides targeting STAT6 and using these exosomes in combination with immune therapy has shown great antitumor effectiveness in mice, resulting in over 90% tumor growth inhibition and 50%–80% complete remissions (Kamerkar et al., 2022).